17
Views
6
CrossRef citations to date
0
Altmetric
Original Article

Systemic and Regional Haemodynamic Effects of 1–(2, 5–Dimethoxy-4–IODO-Phenyl)-2–Aminopropane (DOI) and α-Methyl-5–HT, in the Anaesthetised Rat

, , &
Pages 779-798 | Received 27 Sep 1993, Accepted 04 Apr 1994, Published online: 03 Jul 2009

References

  • Richardson B. P., Engel G., Donatsch P., Stadler P. A. Identification of serotonin M-receptor subtypes and their specific blockade by a new class of drugs. Nature 1985; 316: 126–131
  • Glennon R. A., McKenney J. D., Lyon R. A., Titeler M. 5–HT1 and 5–HT2 binding characteristics of 1–(2, 5–dimethoxy-4–bromophenyl)-2–aminopropane analogues. J Med Chem. 1986; 29: 194
  • Dalton D. W., Feniuk W., Humphrey P. P. A. An investigation into the mechanisms of the cardiovascular effects of 5–hydroxytryptamine in conscious normotensive and doca-salt hypertensive rats. J Auton Pharmacol. 1986; 6: 219–228
  • Dabiré H., Chaouche-Teyara K., Cherqui C., Fournier B., Laubie M., Schmitt H. Characterization of DOI, a putative 5–HT2 receptor agonist in the rat. Eur J Pharmacol. 1989a; 168: 369–374
  • Dabiré H., Chaouche-Teyara K., Cherqui C., Fournier B., Schmitt H. DOI is a mixed agonist-antagonist at postjunctional 5–HT2 receptors in the pithed rat. Eur J Pharmacol. 1989b; 170: 109–111
  • Chaouche-Teyara K., Fournier B., Safar M., Dabiré H. Vascular and cardiac effects of α-methyl-5–HT and DOI are mediated by different 5–HT receptors in the pithed rat. Eur J Pharmacol. 1993; 250: 67–75
  • Ramage A. G., Shepheard S. L., Jordan D., Koss M. C. Can the 5–HT2/1C agonist DOI cause differential sympatho-excitation in nerves supplying the heart in anaesthetized cats?. J Auton Nerv Syst. 1993; 42: 53–62
  • McCall R. B., Patel B. N., Harris L. T. Effects of serotonin1 and serotonin2 receptor agonists and antagonists on blood pressure, heart rate and sympathetic nerve activity. J Pharmacol Exp Ther. 1987; 242: 1152–1157
  • McCall R. B., Harris L. T. 5–HT2 receptor agonists increase spontaneous sympathetic nerve discharge. Eur J Pharmacol. 1988; 151: 113–11
  • Hartley C J, Cole J S. An ultrasonic pulsed doppler system for measuring blood flow in small vessels. J Applied Physiol 1974; 37: 626–9
  • Haywood J R, Shaffer R A, Fastenow G, Fink G D, Brody M J. Regional blood flow measurement with pulsed doppler flowmeter in conscious rat. Am J Physiol 1981; 241: H273–H278
  • Dabiré H., Mouillé P., Andréjak M., Fournier B., Schmitt H. Pre-and postsynaptic α-adrenoceptor blockade by (imidazolinyl-2)-2–benzodioxane 1–4 (170 150): Antagonistic action on the central effects of clonidine. Arch Int Pharmacodyn Ther. 1981; 254: 252–270
  • King K. A., Holtman J. R. Characterization of the effects of activation of ventral medullary serotonin receptor subtypes on cardiovascular activity and respiratory motor outflow to the diaphragm and larynx. J Pharmacol Exp Ther. 1990; 252: 665–674
  • Rittenhouse P. A., Bakkum E. A., Van De Kar L. D. Evidence that the serotonin agonist, DOI, increases renin secretion and blood pressure through both central and peripheral 5–HT2 receptors. J Pharmacol Exp Ther. 1991; 259: 58–65
  • Dedeoglu A., Fisher L. A. Central and peripheral injections of the 5–HT2 agonist, 1–(2, 5–dimethoxy-4–iodophenyl)-2–aminopropane, modify cardiovascular function through different mechanisms. J Pharmacol Exp Ther. 1991; 259: 1027–1034
  • Richer C., Lefevre-Borg F., Lechaire J., Gomeni C., Gomeni R., Giudicelli J. P., Cavero I. Systemic and regional hemodynamic characterization of alpha1 and alpha2 adrenoceptor agonists in the pithed rats. J Pharmacol Exp Ther. 1987; 240: 944–953
  • Mandal A. K., Kellar K. J., Norman W. P., Gillis R. A. Stimulation of serotonin2 receptors in the ventrolateral medulla of the cat results in nonuniform increases in sympathetic outflow. Circ Res. 1990; 67: 1267–1280
  • Shepheard S. L., Jordan D., Ramage A. G. Investigations of the effects of IVth ventricular administration of the 5–HT2 agonist, 1–(2, 5–dimethoxy-4–iodophenyl)-2–aminopropane (DOI), on autonomic outflow in the anaesthetized cat. Br J Pharmacol. 1991; 104: 367–372
  • Copp F. C., Green A. F., Hodson H. F., Randall A. W., Sim M. F. New peripheral antagonists of 5–hydroxytryptamine. Nature 1967; 214: 200–201
  • Fuller R. W., Kurz K. D., Mason N. R., Cohen M. L. Antagonism of a peripheral vascular but not an apparently central serotonergic response by xylamidine and BW 501C67. Eur J Pharmacol. 1986; 125: 71–77
  • Bagdy G., Calogero A. E., Murphy D. L., Szemeredi K. Serotonin agonists cause parallel activation of the sympathoadrenomedullary system and the hypothalamo-pituitary-adrenocortical axis in conscious rats. Endocrinology 1989; 125: 2664–2669
  • Hoyer D. Molecular pharmacology and biology of 5–HT1C receptors. Trends Pharmacol Sci. 1988a; 9: 89–93
  • Hoyer D. Functional correlates of serotonin 5–HT1 recognition sites. J Recep Res. 1988b; 8: 59–81

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.